Previous 10 | Next 10 |
Ayala Pharmaceuticals press release ( NASDAQ: AYLA ): Q2 GAAP EPS of -$0.54 beats by $0.11 . Collaboration revenue was $38 thousand for the second quarter of 2022, as compared to $761 thousand for the corresponding quarter in 2021. Cash Position: Cash and cash equi...
Interim data from Part A of the RINGSIDE study demonstrated substantial initial anti-tumor activity for AL102 as a single agent and supports continued development More advanced and comprehensive data set from RINGSIDE to be presented at ESMO REHOVOT, Israel and WILMINGTON,...
Eliem Therapeutics ELYM -25% on report to discontinue development of lead asset as mid-stage pain trial fails . Mobile Global Esports (MGAM) -14% . Senti Biosciences ( SNTI ) -10% . Celyad Oncology ( CYAD ) -11% . Eos Energy Enterprises EOSE...
Who doesn’t love a good breakout? If you’re trying to hunt down the best penny stocks to buy now, you’ve likely seen one or two big movers over the last few weeks. Whether it was EVFM stock earlier in July, HKD stock last week, or several monster movers today, the thril...
Gainers: Ayala Pharmaceuticals ( AYLA ) +27% . GeoVax Labs ( GOVX ) +20% . Senti Biosciences ( SNTI ) +17% . Omeros ( OMER ) +15% . CVRx ( CVRX ) +9% . Losers: Nutriband ( NTRB ) -15% . Bausch Health Companies ...
Thinking about buying stock in Ayala Pharmaceuticals, Kaltura, Plug Power, Ford Motor, or FuelCell Energy? PR Newswire NEW YORK , July 29, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AYLA, KLTR, PLUG, F, and FCEL. ...
Ayala Pharmaceuticals ( AYLA ) +51% . Senti Biosciences ( SNTI ) +22% . ToughBuilt Industries ( TBLT ) +22% . Sarepta Therapeutics ( SRPT ) +13% on plans for US filing for gene therapy for neuromuscular disorder. Kaltura ( KLTR )...
OBsEVA ( OBSV ) -73% on plans for restructuring after setback for uterine fibroids drug. F45 Training Holdings FXLV -57% on slashed guidance, job cuts, CEO exit. Cassava Sciences SAVA -24% on report of criminal probe linked to Alzheimer’s drug....
AYLA Traded Higher On Unusual Volume. On July 25, Ayala filed a request to withdraw its S-1 Registration statement for the public offering it filed on July 18. The stock closed at $0.87 per share, then traded as high as $2.42 per share (up 178%) before closing at $1.69 per share on July 26. Da...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Shutterstock Mercury Systems (NASDAQ: MRCY ) stock is falling on Tuesday after getting hit with a short report from Glasshouse . That coverage from Glasshouse has it kicking off MRCY stock with a ...
News, Short Squeeze, Breakout and More Instantly...
Ayala Pharmaceuticals Inc. Company Name:
AYLA Stock Symbol:
NASDAQ Market:
Successful End-of-Phase 2 meeting with FDA regarding AL102 for the treatment of desmoid tumors Enrollment in the Phase 3 segment of RINGSIDE trial evaluating AL102 continuing globally as planned Definitive merger agreement with Biosight, expected to close near end of Q3 2023 REHOVOT...
REHOVOT, Israel and MONMOUTH JUNCTION, N.J., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Ayala Pharmaceuticals, Inc. (OTCQX: ADXS), a publicly-traded clinical-stage oncology company, today announced that it will present posters on its gamma secretase inhibitors AL102 and AL101 at the European Societ...
Company confirms FDA agreement on key elements of the Phase 3 segment of ongoing RINGSIDE study, including dosing regimen of 1.2mg once daily Enrollment in Phase 3 continuing as planned REHOVOT, Israel & MONMOUTH JUNCTION, N.J., July 05, 2023 (GLOBE NEWSWIRE) -- Ayala Pharmace...